DOD-R Stock Overview
Operates as a manufacturer of dietary supplements, cosmetics, and skin care products in Thailand.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
DOD Biotech Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿2.50 |
| 52 Week High | ฿3.96 |
| 52 Week Low | ฿1.30 |
| Beta | 1.24 |
| 11 Month Change | -10.71% |
| 3 Month Change | 43.68% |
| 1 Year Change | -35.23% |
| 33 Year Change | -78.07% |
| 5 Year Change | -73.55% |
| Change since IPO | -82.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| DOD-R | TH Personal Products | TH Market | |
|---|---|---|---|
| 7D | -2.3% | -1.7% | 0.04% |
| 1Y | -35.2% | -4.3% | 2.8% |
Return vs Industry: DOD-R underperformed the TH Personal Products industry which returned -4.3% over the past year.
Return vs Market: DOD-R underperformed the TH Market which returned 2.8% over the past year.
Price Volatility
| DOD-R volatility | |
|---|---|
| DOD-R Average Weekly Movement | 9.8% |
| Personal Products Industry Average Movement | 6.2% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in TH Market | 10.9% |
| 10% least volatile stocks in TH Market | 2.5% |
Stable Share Price: DOD-R's share price has been volatile over the past 3 months compared to the TH market.
Volatility Over Time: DOD-R's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of TH stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | Torlarp Chaiyachow | www.dodbiotech.com |
DOD Biotech Public Company Limited operates as a manufacturer of dietary supplements, cosmetics, and skin care products in Thailand. The company offers skincare products, which includes skin clarifying, anti-aging, moisturing, acne control, and dark spot reduction products; and body shaping products, such as metabolic boosting, carbohydrate absorption inhibitors and carb blockers, fat metabolism inhibitors, and DAppetite suppressants. It also provides products for health care, such as brain function, bone and joints, excretory system, sleep aid, immunity boost, vitamins, and blood sugar regulators, as well as visual, hair, and cardiovascular care products; proteins for strengths and muscle function including whey/plant based proteins, power gels, and energy drinks; and body wellness products for men and ladies.
DOD Biotech Public Company Limited Fundamentals Summary
| DOD-R fundamental statistics | |
|---|---|
| Market cap | ฿1.13b |
| Earnings (TTM) | -฿135.93m |
| Revenue (TTM) | ฿725.37m |
1.6x
P/S Ratio-8.3x
P/E RatioIs DOD-R overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DOD-R income statement (TTM) | |
|---|---|
| Revenue | ฿725.37m |
| Cost of Revenue | ฿472.34m |
| Gross Profit | ฿253.03m |
| Other Expenses | ฿388.96m |
| Earnings | -฿135.93m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.30 |
| Gross Margin | 34.88% |
| Net Profit Margin | -18.74% |
| Debt/Equity Ratio | 10.0% |
How did DOD-R perform over the long term?
See historical performance and comparison